Oryzon Genomics S.A. (BME: ORY)
Spain
· Delayed Price · Currency is EUR 1.464
-0.006 (-0.41%)
Jan 17, 2025, 5:35 PM CET
Oryzon Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -3.35 | -4.23 | -4.69 | -3.4 | -3.68 | Upgrade
|
| Depreciation & Amortization | - | 0.13 | 0.15 | 0.13 | 0.13 | 0.14 | Upgrade
|
| Other Amortization | - | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0 | 0 | 0.01 | Upgrade
|
| Other Operating Activities | - | 3.39 | 0.96 | -1.22 | -0.34 | -0.67 | Upgrade
|
| Change in Accounts Receivable | - | 0.34 | 0.29 | -0.11 | 0.16 | -0.32 | Upgrade
|
| Change in Inventory | - | 0 | 0.09 | 0.21 | -0.03 | -0.15 | Upgrade
|
| Change in Accounts Payable | - | -1.13 | 0.87 | 1.21 | -1.37 | 0.64 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.03 | 0 | 0.82 | 0.02 | 0.09 | Upgrade
|
| Operating Cash Flow | - | -0.57 | -1.85 | -3.63 | -4.82 | -3.93 | Upgrade
|
| Capital Expenditures | - | - | -0.08 | -0.18 | -0.15 | -0.12 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -14.5 | -14.2 | -11.59 | -9.07 | -9.47 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 0.01 | Upgrade
|
| Other Investing Activities | - | -0 | -0 | 0.04 | 0.14 | - | Upgrade
|
| Investing Cash Flow | - | -14.5 | -14.27 | -11.72 | -9.08 | -9.58 | Upgrade
|
| Short-Term Debt Issued | - | 13.77 | 8.95 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 1.74 | 5.11 | 7.96 | 7.07 | 4.41 | Upgrade
|
| Total Debt Issued | - | 15.51 | 14.07 | 7.96 | 7.07 | 4.41 | Upgrade
|
| Short-Term Debt Repaid | - | -0.81 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -6.8 | -4.43 | -3.84 | -6.87 | -8.52 | Upgrade
|
| Total Debt Repaid | - | -7.61 | -4.43 | -3.84 | -6.87 | -8.52 | Upgrade
|
| Net Debt Issued (Repaid) | - | 7.9 | 9.64 | 4.12 | 0.2 | -4.11 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 17.96 | 18.3 | Upgrade
|
| Repurchase of Common Stock | - | -1.8 | -1 | - | - | - | Upgrade
|
| Other Financing Activities | - | -0.08 | 0.07 | - | 0.23 | 0.08 | Upgrade
|
| Financing Cash Flow | - | 6.02 | 8.71 | 4.12 | 18.38 | 14.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0 | 0 | 0.35 | 0.01 | 0.04 | Upgrade
|
| Net Cash Flow | - | -9.06 | -7.41 | -10.88 | 4.49 | 0.79 | Upgrade
|
| Free Cash Flow | - | -0.57 | -1.92 | -3.8 | -4.97 | -4.05 | Upgrade
|
| Free Cash Flow Margin | - | -4.05% | -12.25% | -35.81% | -52.20% | -39.40% | Upgrade
|
| Free Cash Flow Per Share | - | -0.01 | -0.03 | -0.07 | -0.09 | -0.09 | Upgrade
|
| Cash Interest Paid | - | 0.4 | 0.32 | 0.26 | 0.25 | 0.34 | Upgrade
|
| Cash Income Tax Paid | - | -4.67 | -2.48 | -1.3 | -0.86 | - | Upgrade
|
| Levered Free Cash Flow | - | -18.62 | -16.17 | -15.73 | -13.5 | -11.65 | Upgrade
|
| Unlevered Free Cash Flow | - | -17.44 | -15.47 | -15.44 | -13.21 | -11.16 | Upgrade
|
| Change in Net Working Capital | - | 0.23 | -2.07 | -0.56 | 1.45 | -0.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.